alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 63, Number 148 (Monday, August 3, 1998)]
[Rules and Regulations]
[Page 41188]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20531]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 510


Animal Drugs, Feeds, and Related Products; Change of Sponsor

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect the change of sponsor for an approved new 
animal drug application (NADA) from Ohmeda Pharmaceutical Products 
Division, Inc., to Baxter Pharmaceutical Products, Inc.

EFFECTIVE DATE: August 3, 1998.

FOR FURTHER INFORMATION CONTACT: Thomas J. McKay, Center for Veterinary 
Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 301-827-0213.

SUPPLEMENTARY INFORMATION: Ohmeda Pharmaceutical Products Division, 
Inc., Liberty Corner, NJ 07938-0804, has informed FDA that it has 
transferred the ownership of, and all rights and interests in, approved 
NADA 135-773 (isoflurane) to Baxter Pharmaceutical Products, Inc., 110 
Allen Rd., P.O. Box 804, Liberty Corner, NJ 07938. The new sponsor will 
retain the drug labeler code for Ohmeda, Pharmaceutical Products, Inc. 
The agency is amending the regulations in 21 CFR 510.600(c)(1) and 
(c)(2) to reflect the new sponsor name.

List of Subject in 21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.
    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is 
amended as follows:

PART 510--NEW ANIMAL DRUGS

    1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.


Sec.  510.600  [Amended]

    2. Section 510.600 Names, addresses, and drug labeler codes of 
sponsors of approved applications is amended in the table in paragraph 
(c)(1) by removing the entry for ``Ohmeda Pharmaceutical Products 
Division, Inc.,'' and by alphabetically adding an entry for ``Baxter 
Pharmaceutical Products, Inc., 110 Allen Rd., Liberty Corner, NJ 
07938''; and in the table in paragraph (c)(2) in the entry for 
``010019'' by removing the sponsor name ``Ohmeda Pharmaceutical 
Products Division, Inc.,'' and adding in its place ``Baxter 
Pharmaceutical Products, Inc., 110 Allen Rd.,''.

    Dated: July 10, 1998.
Margaret Ann Miller,
Acting Director, Office of New Animal Drug Evaluation, Center for 
Veterinary Medicine.
[FR Doc. 98-20531 Filed 7-31-98; 8:45 am]
BILLING CODE 4160-01-F
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3527 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 3527

 To amend title 38, United States Code, to assign the highest priority 
  status for hospital care and medical services provided through the 
Department of Veterans Affairs to veterans who are former prisoners of 
                                  war.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 27, 2019

  Mr. Walberg (for himself, Mr. Krishnamoorthi, Mr. Guthrie, and Mr. 
    Rush) introduced the following bill; which was referred to the 
                     Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
 To amend title 38, United States Code, to assign the highest priority 
  status for hospital care and medical services provided through the 
Department of Veterans Affairs to veterans who are former prisoners of 
                                  war.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``POW Priority Care Act of 2019''.

SEC. 2. HIGHEST PRIORITY STATUS FOR ENROLLMENT OF FORMER PRISONERS OF 
              WAR IN HEALTH CARE SYSTEM OF DEPARTMENT OF VETERANS 
              AFFAIRS.

    (a) Enrollment.--Section 1705(a) of title 38, United States Code, 
is amended--
            (1) in paragraph (1)--
                    (A) by striking ``and veterans'' and inserting ``, 
                veterans''; and
                    (B) by striking the period at the end and inserting 
                ``, and veterans who are former prisoners of war.''; 
                and
            (2) in paragraph (3), by striking ``who are former 
        prisoners of war or''.
    (b) Extended Care Services.--Section 1710B(c)(2)(D) of such title 
is amended by inserting ``a veteran who is a former prisoner of war 
or'' before ``a veteran who''.
    (c) Applicability.--The amendments made by this section shall apply 
with respect to veterans who are former prisoners of war before, on, or 
after the date of the enactment of this Act.
                                 <all>
```
From: Gossett, Stephen R [mailto:srgosset@eastman.com] 

Sent: Friday, June 13, 2014 8:23 PM 

To: Jones, Toni 

Subject: Submittal of Additional NOx Emissions Data Boiler 18 

Toni, I am sending on behalf of Eastman Chemical Company (Eastman) the attached documents to 

supplement Eastman’s petition to EPA (dated April 5, 2013) to reconsider, amend, and administratively 

stay certain provisions of the Commercial and Industrial Solid Waste Incineration Units (CISWI) final rule 

dated February 7, 2013. If there are any questions concerning this submittal, please contact me at 

(423)229-2327. 

I will be on vacation all of next week. I hope this data submittal is timely and will be of use to EPA. 

Steve Gossett 

Eastman Chemical Company 

423-229-2327
| (logo) WELLS  FARGO | **Commercial  Mortgage Servicing**D1050-084,  8th Floor  401 South Tryon Street  Charlotte, NC 28202  1-800-326-1334 |
|---------------------|----------------------------------------------------------------------------------------------------------------------|

 

 

**ANNUAL STATEMENT OFCOMPLIANCE**

 

 

Referenceis hereby made to that certain Pooling and Servicing Agreement dated as ofAugust 1, 2017, by and among GS MORTGAGE SECURITIES CORPORATION II, asDepositor, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Master Servicer, RIALTOCAPITAL ADVISORS, LLC, as Special Servicer, WELLS FARGO BANK, NATIONALASSOCIATION, as Certificate Administrator and Cayman Agent, WILMINGTON TRUST,NATIONAL ASSOCIATION, as Trustee and PARK BRIDGE LENDER SERVICES LLC, asOperating Advisor and as Asset Representations Reviewer with respect toCommercial Mortgage Pass-Through Certificates Series 2017-GS7 (the"Agreement"). Capitalized terms used herein not otherwise definedshall have the meanings assigned in the Agreement.

 

Pursuant to Section 11.09 of this Agreement, I, DanielBober, Executive Vice President of Commercial Mortgage Services do herebycertify that:

 

1.A review of the activities of the Master Servicer during the period from August1, 2017 through December 31, 2017 (the “Reporting Period”), and of itsperformance per the Agreement during such period has been made under mysupervision, and 

 

2.To the best of my knowledge, based on such review, the Master Servicer hasfulfilled all of its obligations under the Agreement in all material respectsthroughout the Reporting Period.

 

INWITNESS WHEREOF, the undersigned has executed this Certificate as of the 28thday of February 2018.

 

 

/s/Daniel Bober

DanielBober

ExecutiveVice President

WellsFargo Bank

 

 

WellsFargo Bank,N.A.                                                                                                        (logo)Together we’ll go far
Summary of Named Executive Officers Annual compensations for fiscal 2012



 EXHIBIT 10.15 

 
 SUMMARY OF NAMED EXECUTIVE OFFICERS’ COMPENSATION FOR FISCAL
2012 
 Base Salaries.    Following are the current annual base salaries for the executive
officers employed the Company as of April 4, 2012, who will be included in the Company’s Proxy Statement to be filed with the Securities and Exchange Commission for the Company’s 2012 Annual Meeting of Shareholders (the “Named
Executive Officers”): 
  

							
	     Named Executive Officer    
	  	 Title
	  	Annual Base
Salary	 
	 Gary H. Schoenfeld
	  	President, Chief Executive Officer and Director	  	$	1,050,000	  
	 Michael W. Kaplan
	  	Senior Vice President and Chief Financial Officer	  	$	425,000	  
	 Paula M. Lentini
	  	Senior Vice President, Retail	  	$	425,000	  
	 Charles Mescher
	  	Senior Vice President, Men’s Merchandising	  	$	415,000	  
	 Christine Lee
	  	Senior Vice President, Women’s Merchandising	  	$	415,000	  

 Annual Bonuses.    The Company provides each of the Named Executive Officers
with an annual incentive bonus opportunity pursuant to a broad-based bonus plan which covers the other executives of the Company and the non-retail managers of the Company. Actual bonus amounts are determined by a combination of (i) the
Company’s achievement of pre-set financial targets, and (ii) the individual’s achievement of personal and/or department goals. All bonuses are approved by the Compensation Committee of the Company’s Board of Directors.
Mr. Schoenfeld’s target incentive bonus is 100% of his base salary with a maximum incentive bonus of 200% of his base salary. All other Named Executive Officers have a target incentive bonus of 50% of his or her base salary with a maximum
incentive bonus of 100% of his or her base salary. 
 Additional
Compensation.    The Named Executive Officers are also entitled to participate in various Company plans, including equity plans, and may be subject to other written agreements, in each case as set forth in
exhibits to the Company’s filings with the Securities and Exchange Commission. In addition, the Named Executive Officers may be eligible to receive perquisites and other personal benefits as disclosed in the Company’s proxy statements
filed with the Securities and Exchange Commission in connection with the Company’s annual meetings of shareholders.
No. 11-7545.

#### Percell Burrows, Petitioner v. United States.

565 U.S. 1134, 132 S. Ct. 1059,

181 L. Ed. 2d 776,

2012 U.S. LEXIS 89.

January 9, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Same case below, 438 Fed. Appx. 180.
Exhibit 35.1



Servicer Compliance Statement of AmeriCredit Financial Services,
Inc.



This Annual Statement as to Compliance
is delivered to you pursuant to Section 2.9 (c) of the 2017-3 Servicing Supplement dated as of July 31, 2017 (the “Agreement”)
and Item 1123 of Regulation AB, executed in connection with the formation of GM Financial Automobile Leasing Trust 2017-3 (the
“Trust”), the issuance of the Notes by the Trust and the closing of the transactions and the execution and delivery
of the various documents by AmeriCredit Financial Services, Inc. (the “Servicer”) and GMF Leasing LLC in connection
therewith. The capitalized terms used herein shall have the same meanings as in the Agreement.



The undersigned certifies
that I am the Executive Vice President, Corporate Controller and Chief Accounting Officer of the Servicer. I further certify as
follows:



| | 1. | I have conducted, or caused to be conducted under my supervision, a review of the Servicer during
the preceding period from January 1, 2019 through December 31, 2019, and its performance under the Agreement.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To the best of my knowledge, following such review, the Servicer has fulfilled all its obligations
under the Agreement throughout such period, and, to the best of my knowledge, there has been no default in the fulfillment of any
such obligation.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|AmeriCredit Financial Services, Inc. |                                             | 
|------------------------------------ | ------------------------------------------- | 
|                                     |                                             | 
|By:                                  | /s/ Connie Coffey                           | 
|                                     | Connie Coffey                               | 
|                                     | Executive Vice President, Corporate         | 
|                                     | Controller and Chief Accounting
    Officer |
| (logo) **ncb**  National Cooperative Bank    | 2011 Crystal  Drive  Suite, 8oo  Arlington, VA 22202 |
|---------------------------------------------------|-----------------------------------------------------------|

 

 

**FORM OF ANNUAL COMPLIANCE STATEMENT**

 

 

CERTIFICATION

 

BANK 2017-BNK6, Commercial Mortgage Pass-ThroughCertificates, Series 2017-BNK6 (the “Trust”)

 

I,Karyn Mann, on behalf of National Cooperative Bank, N.A., as NCB MasterServicer (the “Certifying Servicer”), certify to Bancof America MerrillLynch Commercial Mortgage Inc. and its officers, directors and affiliates, andwith the knowledge and intent that they will rely upon this certification,that:

 

1.       I (or ServicingOfficers under my supervision) have reviewed the Certifying Servicer’sactivities during the preceding calendar year between January 1, 2018 andDecember 31, 2018 (the “Reporting Period”) and theCertifying Servicer’sperformance under the Pooling and Servicing Agreement; and

 

2.       To the best of myknowledge, based on such review, the Certifying Servicer has fulfilled all ofits obligations under the Pooling and Servicing Agreement in all materialrespects during the Reporting Period.

 

 

Date:February 6, 2019

 

 

NATIONALCOOPERATIVE BANK, N.A.,

asNCB Master Servicer

By:/s/ Karyn Mann

Name:Karyn Mann

Title:Senior Vice President
June 05, 2023 DLA-SM-23-3234

DLA STRATEGIC MATERIALS ANNOUNCES

BOA SALES FOR May 2023

Fort Belvoir, VA - The Defense Logistics Agency Strategic Materials today announced sales made 

under the following Basic Ordering Agreements (BOA) during May 2023.

SOLICITATION:

DLA-Stockpile Materials-001

UNIT QUANTITY 

SOLD

APPROX 

VALUE

COMPANY

Ferrochrome Amendment 001 LC ST

HC ST

1,000 $2.32 M *

Ferromanganese Amendment 001 ST NO

SALES

Chromium Metal Amendment 001 ST 172.6 $1.52 M

CCMA LLC, 

Veritas Alloys & 

Metals, 

Voss Metals

Tungsten Ores and Concentrates 

Amendment 001

Lbs W 198,575 $3.0 M

*

Tin Amendment 001 MT 40 $970 K

*

 *If no company name appears, the single awardee name has been withheld
**Exhibit 32.3**

 

**Written Statement of the Chief Operating Officer**

 

**Pursuant to 18 U.S.C.**'**1350**

 

Solely for thepurposes of complying with 18 U.S.C. '1350, I, the undersigned President and Chief Operating Officer of Regency Centers Corporation, the general partner of **Regency Centers, L.P.** (the “Company”),hereby certify, based on my knowledge*,* that the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2004 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

Date: August 5, 2004 

 

/s/ Mary Lou Fiala

Mary Lou Fiala****

Chief Operating Officer
### Evansville-Vanderburgh Airport Authority District 

# easy.

February 24, 2010

The Honorable Raymond H. LaHood Secretary U.S. Department ofTransportation 1200 New Jersey Ave, SE Washington, DC 20590 Docket DOT-OST-2010-_ Dear Mr. Secretary: 

### Evansville Regional Airport 7801 Bussing Drive Evansville, IN 47725-6799 (812) 421-4401 Office (812) 421-4412 Fax www.evvairport.com

# '~'l!m~ S10-100303-017 CONTROL NO

Thank you for the opportunityto express Evansville-Vanderburgh Airport Authority District's support for theapplication**for~ntitrust** immunity and proposed joint business agreement filed by American Airlines and JaparlAirlines. The proposed alliance between these two airlines is vital for the oneworld alliance tocompet'e effectivelYwith the Star and SkyTeam alliances. This increased alliance competition will in turnenharice the benefits ofthe Department's Open Skies policy - first by solidifying U.S. - Japan Open Skies, then by servingas a foundation forfurther liberalization across Asia. After athorough review, we encourage the Department ofTransportation to approve this application as itwould enable these oneworld alliance airlines to work closely together to deliver highly competitive air transportation services. Approval for AA/JAL alliance will have a positive impact on air travel by offering customers more service, scheduling and pricing options and will help to ensure that customers continue to benefit from the competition afforded by three competitive air alliances
.

.We urge you to quicklyapprove this application. Sincerely,

# ~=.~~:!:) Airport Manager Evansville-Vanderburgh AirportAuthority District 7801 Bussing Drive 'Evansville, Indiana 47725
No. 11-6759.

#### Eric Hayes, Petitioner v. United States.

565 U.S. 1020, 132 S. Ct. 565,

181 L. Ed. 2d 407,

2011 U.S. LEXIS 8032.

November 7, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.

Same case below, 434 Fed. Appx. 94.
No. 11-7041.

#### Michael Kelley, Petitioner v. Henry C. Ritter, et al.

565 U.S. 1121, 132 S. Ct. 1021,

181 L. Ed. 2d 753,

2012 U.S. LEXIS 194.

January 9, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
IB 

Union Calendar No. 178 

116TH CONGRESS 

1ST SESSION H. R. 3405 

[Report No. 116–225] 

To direct the Secretary of the Interior to revise the Final List of Critical 

Minerals, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 21, 2019 

Mr. GRIJALVA (for himself and Mr. LOWENTHAL) introduced the following 

bill; which was referred to the Committee on Natural Resources 

OCTOBER 4, 2019 

Additional sponsor: Mr. TED LIEU of California 

OCTOBER 4, 2019 

Reported with an amendment, committed to the Committee of the Whole 

House on the State of the Union, and ordered to be printed 

[Strike out all after the enacting clause and insert the part printed in italic] 

[For text of introduced bill, see copy of bill as June 21, 2019] 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 3405 RH

A BILL 

To direct the Secretary of the Interior to revise the Final 

List of Critical Minerals, and for other purposes. 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 3405 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Uranium Classification 

5 Act of 2019’’. 

6 SEC. 2. REVISION OF FINAL RULE REGARDING CRITICAL 

7 MINERALS. 

8 (a) IN GENERAL.—Not later than 60 days after the 

9 date of enactment of this Act, the Secretary of the Interior 

10 shall revise the Final List of Critical Minerals, and any 

11 related regulations, to remove uranium from such list. 

12 (b) RESTRICTION.—The Secretary of the Interior may 

13 not add uranium to the Final List of Critical Minerals. 

14 (c) FINAL LIST OF CRITICAL MINERALS.—The term 

15 ‘‘Final List of Critical Minerals’’ means the Final List of 

16 Critical Minerals issued pursuant to Executive Order 13817 

17 (82 Fed. Reg. 60835, relating to a Federal strategy to en18 sure secure and reliable supplies of critical minerals). 


pamtmann on DSKBC07HB2PROD with BILLS
Union Calendar No. 178 

116TH CONGRESS 

1ST SESSION H. R. 3405 

[Report No. 116–225] 

A BILL 

To direct the Secretary of the Interior to revise the 

purposes. Final List of Critical Minerals, and for other 

OCTOBER 4, 2019 

Reported with an amendment, committed to the Comand ordered to be printed mittee of the Whole House on the State of the Union, 


pamtmann on DSKBC07HB2PROD with BILLS
CDSi Resources

Quick Guide

1

Calculating Dates

To determine if a target dose is valid or not valid, based on age, the Logic Specification contains business rules to ensure 

consistency in calculating dates.

This quick guide provides information on:

•

•

Date calculation rules

Calculating dates to determine validity of dose

Date Calculation Rules

When calculating dates there are a few important rules to remember.

Calculation Type Business Rule ID Rule Example

Adding years CALCDT-1 Adjust only the year not the month 

and days.

January 1, 2000

+ 3 years

January 1, 2003

Adding months CALCDT-2 Adjust only the month, and if 

necessary the year, but not the day.

January 1, 2000

+ 3 months

April 1, 2000

Adding weeks or days CALCDT-3

Convert each week to 7 days, and 

add the total number of days to the 

date.

February 1,

+ 5 weeks (or 35 days)

March 8

Invalid date modification CALCDT-5

Sometimes these rules can result

in a date that does not exist. If this

occurs, move to the first day of 

the following month.

July 31

+ 2 months

September 31

(October 1)

Calculate Dates to Determine Validity of Dose

1 Determine the minimum age for specified dose, found in the supporting data. 

Series Dose Dose 4

Age

Absolute Minimum Age

12 Months - 4 Days

Minimum age

1 12 months
2

2 Add the minimum age to the patient’s date of birth, resulting in the minimum age date.

Target Dose

Minimum Age:

12 Months - 4 Days

Patient

DOB:

8/6/08

Minimum Age

Date:

8/2/09

3 Compare the minimum age date with the patient’s dose administered date to determine if the dose is valid: 

Valid – The dose administered date occurs on or after the minimum age date. 

Not Valid – The dose administered date occurs before the minimum age date.

Minimum Age

Date:

8/2/09

Minimum Age

Date:

8/2/09

Dose 

Administered

Date:

9/7/09

Dose 

Administered

Date:

6/7/09

Valid

Not Valid

www.cdc.gov/vaccines/programs/iis/cdsi.html
No. 11-6543.

#### Errol Underwood, Petitioner v. Kathy Prosper, Warden.

565 U.S. 1066, 132 S. Ct. 772,

181 L. Ed. 2d 496,

2011 U.S. LEXIS 8625.

November 28, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.